1. Up Front

   Up Front 27 May 2023 Pages: 1167 - 1168

   

2. The countdown to type 1 diabetes: when, how and why does the clock start?

   • Anette-Gabriele Ziegler

   Review Open access 26 May 2023 Pages: 1169 - 1178

   

3. Effects of postprandial exercise on blood glucose levels in adults with type 1 diabetes: a review

   • Simon Helleputte
   • Jane E. Yardley
   • Patrick Calders

   Review 04 April 2023 Pages: 1179 - 1191

   

4. The effect of surgical weight loss on diabetes complications in individuals with class II/III obesity

   • Evan L. Reynolds
   • Maya Watanabe
   • Brian C. Callaghan

   Article 14 March 2023 Pages: 1192 - 1207

   

5. Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trial

   • Christian Laugesen
   • Ajenthen G. Ranjan
   • Kirsten Nørgaard

   Article Open access 11 April 2023 Pages: 1208 - 1217

   

6. Childhood adversity and risk of type 2 diabetes in early adulthood: results from a population-wide cohort study of 1.2 million individuals

   • Leonie K. Elsenburg
   • Jessica Bengtsson
   • Naja H. Rod

   Short Communication 20 April 2023 Pages: 1218 - 1222

   

7. Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes

   • Melanie Lloyd
   • Jedidiah Morton
   • Zanfina Ademi

   Article Open access 18 March 2023 Pages: 1223 - 1234

   

8. Racial difference in the association between non-alcoholic fatty liver disease and incident type 2 diabetes: findings from the CARDIA study

   • Yu Hatano
   • Lisa B. VanWagner
   • Yuichiro Yano

   Article 21 March 2023 Pages: 1235 - 1246

   

9. Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation

   • Diana L. Juvinao-Quintero
   • Gemma C. Sharp
   • Hannah R. Elliott

   Article Open access 19 May 2023 Pages: 1247 - 1259

   

10. Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH

    • Josephine H. Li
    • Laura N. Brenner
    • Jose C. Florez

    Article 26 May 2023 Pages: 1260 - 1272

    

11. The power of TOPMed imputation for the discovery of Latino-enriched rare variants associated with type 2 diabetes

    • Alicia Huerta-Chagoya
    • Philip Schroeder
    • Josep M. Mercader

    Article Open access 06 May 2023 Pages: 1273 - 1288

    

12. Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover

    • Mi Huang
    • Melina Claussnitzer
    • Paul W. Franks

    Article Open access 12 May 2023 Pages: 1289 - 1305

    

13. GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models

    • Vyron Gorgogietas
    • Bahareh Rajaei
    • Mariana Igoillo-Esteve

    Article Open access 30 March 2023 Pages: 1306 - 1321

    

14. Hepatic p38α MAPK controls gluconeogenesis via FOXO1 phosphorylation at S273 during glucagon signalling in mice

    • Wanbao Yang
    • Wang Liao
    • Shaodong Guo

    Article 19 May 2023 Pages: 1322 - 1339

    

15. Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes

    • Alison D. McNeilly
    • Jennifer R. Gallagher
    • on behalf of the Hypo-RESOLVE Consortium

    Article Open access 04 April 2023 Pages: 1340 - 1352